tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life Buys Back 149,000 Shares Under Ongoing Programme

Story Highlights
  • Venture Life repurchased 149,000 ordinary shares at 66.88 pence each for treasury.
  • Post-buyback, voting rights stand at 124,953,949, adjusting shareholder notification thresholds.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life Buys Back 149,000 Shares Under Ongoing Programme

Claim 50% Off TipRanks Premium

An update from Venture Life ( (GB:VLG) ) is now available.

Venture Life Group has repurchased 149,000 of its own ordinary shares at a volume-weighted average price of 66.88 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,812,145 ordinary shares in issue, of which 3,858,196 are held in treasury, leaving 124,953,949 voting rights in circulation, a change that may affect shareholder notification thresholds and reflects continued use of capital management tools to adjust its share base and potentially enhance shareholder value.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group plc is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector, with a focus on proactive healthy longevity and product innovation. Its portfolio spans women’s intimate healthcare brand Balance Activ, ENT care product Earol, Lift and Glucogel ranges for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, sold via pharmacies, health and beauty retailers, grocery multiples and e-commerce, both directly in key markets such as the UK, Ireland and the USA and through international distribution partners elsewhere.

Average Trading Volume: 231,418

Technical Sentiment Signal: Buy

Current Market Cap: £84.13M

For detailed information about VLG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1